rs1042484
Variant names:
Variant summary
Our verdict is Benign. The variant received -20 ACMG points: 0P and 20B. BP4_StrongBP6_Very_StrongBA1
The NM_002448.3(MSX1):c.470-47A>G variant causes a intron change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.221 in 1,597,544 control chromosomes in the GnomAD database, including 40,406 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Benign (★★).
Frequency
Genomes: 𝑓 0.20 ( 3176 hom., cov: 34)
Exomes 𝑓: 0.22 ( 37230 hom. )
Consequence
MSX1
NM_002448.3 intron
NM_002448.3 intron
Scores
2
Clinical Significance
Conservation
PhyloP100: -0.634
Genes affected
MSX1 (HGNC:7391): (msh homeobox 1) This gene encodes a member of the muscle segment homeobox gene family. The encoded protein functions as a transcriptional repressor during embryogenesis through interactions with components of the core transcription complex and other homeoproteins. It may also have roles in limb-pattern formation, craniofacial development, particularly odontogenesis, and tumor growth inhibition. Mutations in this gene, which was once known as homeobox 7, have been associated with nonsyndromic cleft lip with or without cleft palate 5, Witkop syndrome, Wolf-Hirschom syndrome, and autosomoal dominant hypodontia. [provided by RefSeq, Jul 2008]
Genome browser will be placed here
ACMG classification
Classification was made for transcript
Our verdict: Benign. The variant received -20 ACMG points.
BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.83).
BP6
Variant 4-4862654-A-G is Benign according to our data. Variant chr4-4862654-A-G is described in ClinVar as [Benign]. Clinvar id is 1241303.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BA1
GnomAd4 highest subpopulation (NFE) allele frequency at 95% confidence interval = 0.231 is higher than 0.05.
Transcripts
RefSeq
Ensembl
Frequencies
GnomAD3 genomes AF: 0.198 AC: 30110AN: 152052Hom.: 3177 Cov.: 34 show subpopulations
GnomAD3 genomes
AF:
AC:
30110
AN:
152052
Hom.:
Cov.:
34
Gnomad AFR
AF:
Gnomad AMI
AF:
Gnomad AMR
AF:
Gnomad ASJ
AF:
Gnomad EAS
AF:
Gnomad SAS
AF:
Gnomad FIN
AF:
Gnomad MID
AF:
Gnomad NFE
AF:
Gnomad OTH
AF:
GnomAD2 exomes AF: 0.204 AC: 48045AN: 235490 AF XY: 0.203 show subpopulations
GnomAD2 exomes
AF:
AC:
48045
AN:
235490
AF XY:
Gnomad AFR exome
AF:
Gnomad AMR exome
AF:
Gnomad ASJ exome
AF:
Gnomad EAS exome
AF:
Gnomad FIN exome
AF:
Gnomad NFE exome
AF:
Gnomad OTH exome
AF:
GnomAD4 exome AF: 0.223 AC: 322526AN: 1445374Hom.: 37230 Cov.: 30 AF XY: 0.222 AC XY: 159589AN XY: 719978 show subpopulations
GnomAD4 exome
AF:
AC:
322526
AN:
1445374
Hom.:
Cov.:
30
AF XY:
AC XY:
159589
AN XY:
719978
Gnomad4 AFR exome
AF:
AC:
4628
AN:
33322
Gnomad4 AMR exome
AF:
AC:
9486
AN:
44712
Gnomad4 ASJ exome
AF:
AC:
6292
AN:
26100
Gnomad4 EAS exome
AF:
AC:
2333
AN:
39660
Gnomad4 SAS exome
AF:
AC:
13705
AN:
86110
Gnomad4 FIN exome
AF:
AC:
11208
AN:
44420
Gnomad4 NFE exome
AF:
AC:
261009
AN:
1105236
Gnomad4 Remaining exome
AF:
AC:
12479
AN:
60058
Heterozygous variant carriers
0
14099
28198
42297
56396
70495
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance
Exome Het
Exome Hom
Variant carriers
0
8780
17560
26340
35120
43900
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome AF: 0.198 AC: 30118AN: 152170Hom.: 3176 Cov.: 34 AF XY: 0.198 AC XY: 14710AN XY: 74408 show subpopulations
GnomAD4 genome
AF:
AC:
30118
AN:
152170
Hom.:
Cov.:
34
AF XY:
AC XY:
14710
AN XY:
74408
Gnomad4 AFR
AF:
AC:
0.141535
AN:
0.141535
Gnomad4 AMR
AF:
AC:
0.203583
AN:
0.203583
Gnomad4 ASJ
AF:
AC:
0.24438
AN:
0.24438
Gnomad4 EAS
AF:
AC:
0.0511781
AN:
0.0511781
Gnomad4 SAS
AF:
AC:
0.149814
AN:
0.149814
Gnomad4 FIN
AF:
AC:
0.260755
AN:
0.260755
Gnomad4 NFE
AF:
AC:
0.233673
AN:
0.233673
Gnomad4 OTH
AF:
AC:
0.200474
AN:
0.200474
Heterozygous variant carriers
0
1287
2574
3862
5149
6436
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance
Genome Het
Genome Hom
Variant carriers
0
320
640
960
1280
1600
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
Hom.:
Bravo
AF:
Asia WGS
AF:
AC:
384
AN:
3478
ClinVar
Significance: Benign
Submissions summary: Benign:2
Revision: criteria provided, multiple submitters, no conflicts
LINK: link
Submissions by phenotype
not provided Benign:2
-
Breakthrough Genomics, Breakthrough Genomics
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:not provided
- -
May 13, 2021
GeneDx
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing
- -
Computational scores
Source:
Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
DANN
Benign
Mutation Taster
=100/0
polymorphism (auto)
Splicing
Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
Details are displayed if max score is > 0.2
Find out detailed SpliceAI scores and Pangolin per-transcript scores at